Carcinoma, Renal Cell
Showing NaN - NaN of 23
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, MK-4830, Belzutifan)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +5 more
-
New Haven, Connecticut
- +38 more
Jan 25, 2023
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +5 more
-
New Haven, Connecticut
- +37 more
Jan 25, 2023
Carcinoma, Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Savolitinib, Sunitinib)
Active, not recruiting
- Carcinoma
- +7 more
-
La Jolla, California
- +58 more
Jan 13, 2023
Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Belzutifan, Pembrolizumab/Quavonlimab)
Recruiting
- Carcinoma, Renal Cell
- Pembrolizumab
- +3 more
-
Birmingham, Alabama
- +229 more
Aug 11, 2022
Carcinoma, Renal Cell Trial in Worldwide (Pazopanib, Sunitinib)
Completed
- Carcinoma, Renal Cell
-
Huntsville, Alabama
- +226 more
Apr 19, 2021
Carcinoma, Renal Cell, Prostatic Tumors Trial in United Kingdom, United States (FK228 (romidepsin))
Completed
- Carcinoma, Renal Cell
- Prostatic Neoplasms
- FK228 (romidepsin)
-
Duarte, California
- +4 more
Nov 14, 2019
Carcinoma, Renal Cell, Tumor Metastasis Trial in Duarte, Chicago, Seattle (FK228 (romidepsin))
Completed
- Carcinoma, Renal Cell
- Neoplasm Metastasis
- FK228 (romidepsin)
-
Duarte, California
- +2 more
Oct 16, 2019
Carcinoma, Renal Cell Trial in United Kingdom, United States (Sorafenib (Nexavar, BAY43-9006), Placebo)
Completed
- Carcinoma, Renal Cell
- Sorafenib (Nexavar, BAY43-9006)
- Placebo
-
Chicago, Illinois
- +6 more
Dec 18, 2014
Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Interferon)
Completed
- Carcinoma, Renal Cell
- Sorafenib (Nexavar, BAY43-9006)
- Interferon
-
Sacramento, California
- +41 more
Oct 24, 2014
Carcinoma, Renal Cell Trial in Canada, United States (Sorafenib (Nexavar, BAY43-9006))
Completed
- Carcinoma, Renal Cell
- Sorafenib (Nexavar, BAY43-9006)
-
Bessemer, Alabama
- +319 more
Aug 5, 2014
Carcinoma, Renal Cell Trial in Chicago (combination of gemcitabine, capecitabine, and bevacizumab)
Terminated
- Carcinoma, Renal Cell
- combination of gemcitabine, capecitabine, and bevacizumab
-
Chicago, IllinoisUniversity of Chicago
Jan 16, 2014
Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)
Completed
- Carcinoma, Renal Cell
- Sorafenib (Nexavar, BAY43-9006)
- Placebo
-
Tucson, Arizona
- +120 more
Jan 8, 2014
Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Interferon Alfa, CCI-779, Interferon Alfa and CCI-779)
Completed
- Carcinoma, Renal Cell
- Kidney Neoplasms
- Interferon Alfa
- +2 more
-
Little Rock, Arkansas
- +153 more
Sep 24, 2012
Kidney Tumors, Carcinoma, Renal Cell Trial in United States (AG-013736 (axitinib))
Completed
- Kidney Neoplasms
- Carcinoma, Renal Cell
- AG-013736 (axitinib)
-
Chicago, Illinois
- +4 more
Jul 23, 2012
Carcinoma, Renal Cell, Kidney Tumors Trial in United States (ZD6126, Placebo)
Suspended
- Carcinoma, Renal Cell
- Kidney Neoplasms
- ZD6126
- Placebo
-
Los Angeles, California
- +15 more
Jan 25, 2011
Carcinoma, Renal Cell Trial in Worldwide (Interferon-alfa, SU011248)
Completed
- Carcinoma, Renal Cell
-
Jonesboro, Arkansas
- +123 more
Jan 19, 2010
Carcinoma, Renal Cell Trial in United States (Recombinant Human Lactoferrin)
Completed
- Carcinoma, Renal Cell
- Recombinant Human Lactoferrin
-
Los Angeles, California
- +5 more
Apr 8, 2008
Carcinoma, Renal Cell, Metastases, Tumor Trial in United States (GTI-2040)
Completed
- Carcinoma, Renal Cell
- Metastases, Neoplasm
-
Concord, California
- +9 more
Jan 4, 2008
Carcinoma, Renal Cell Trial in Netherlands, United States (ABT-510/Thrombospondin-1 mimetic)
Completed
- Carcinoma, Renal Cell
- ABT-510/Thrombospondin-1 mimetic
-
Scottsdale, Arizona
- +17 more
Aug 13, 2007